文献速递冠心病

低度内毒素血症通过Toll样受体4促进动脉血栓生长:对心肌梗死的意义

Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction.
PubMed 文献 · Eur Heart J · 2020-01-01

研究检测了STEMI、稳定型心绞痛患者及对照者的血清LPS、sP-selectin和zonulin水平,并在小鼠中验证E. coli-LPS的血栓特性。结果显示STEMI患者冠状动脉血栓中LPS和sP-selectin升高,肠道通透性增加,LPS通过白细胞TLR4-组织蛋白酶G通路增强血小板聚集和血栓生长。

要点

  • STEMI患者冠状动脉血栓中LPS和sP-selectin浓度显著高于SA冠脉血和对照外周血(P<0.001)。
  • STEMI患者zonulin水平升高并与LPS相关(Rs=0.585,P<0.001),提示肠道通透性增加。
  • E. coli-LPS通过白细胞TLR4介导的组织蛋白酶G激活增强血小板聚集和动脉血栓形成。

核心结论

  • STEMI患者肠道通透性增强导致LPS易位入循环,通过白细胞-血小板相互作用促进动脉病变处血栓生长。

研究设计与样本

  • 病例对照研究:STEMI患者(n=50)、稳定型心绞痛患者(n=50)和对照者(n=50),分别检测外周循环、冠状动脉血栓和冠脉内血的LPS、sP-selectin和zonulin。
  • 小鼠实验评估E. coli-LPS的血栓特性,体外研究探讨LPS对血小板聚集的影响。

主要发现

  • STEMI冠状动脉血栓中LPS和sP-selectin浓度高于SA冠脉血和对照外周血(P<0.001)。
  • STEMI患者zonulin水平为4.57(3.34-5.22)ng/mL,高于SA的2.56(0.41-4.36)ng/mL和对照的1.95(1.22-2.65)ng/mL(P<0.001),且与LPS相关(Rs=0.585;P<0.001)。
  • Escherichia coli DNA在STEMI中阳性率为34%,SA为12%,对照为4%(P<0.001)。
  • 12例STEMI亚组冠状动脉血栓免疫组化显示白细胞TLR4、cathepsin G和E. coli LPS阳性率分别为100%、80%和25%。
  • 小鼠注射E. coli-LPS至冠状动脉血栓中检测浓度可增强动脉血栓形成和血小板活化,TLR4抑制剂共给药可减弱此效应。

临床怎么用

  • STEMI患者应关注肠道通透性标志物zonulin和LPS水平,可能提示血栓风险增加。
  • TLR4通路可能作为减轻LPS相关血栓形成的潜在干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Low-grade endotoxaemia is detectable in human circulation but its role in thrombosis is still unclear. METHODS AND RESULTS: We measured serum lipopolysaccharide (LPS) concentration, soluble P-selectin (sP-selectin), a marker of platelet activation, and zonulin, a marker of gut permeability, in peripheral circulation, coronary thrombi, and intracoronary blood of patients with ST-elevation myocardial infarction (STEMI, n = 50) and stable angina (SA) (n = 50), respectively, and in controls (n = 50). Experimental study was carried out in mice to assess if Escherichia coli-LPS (E. coli-LPS) possess thrombotic property. Coronary thrombi from STEMI showed higher concentrations of LPS, sP-selectin vs. intracoronary blood of SA and peripheral blood of controls (P < 0.001). Zonulin was higher in STEMI compared to the other two groups [4.57 (3.34-5.22); 2.56 (0.41-4.36); 1.95 (1.22-2.65) ng/mL; P < 0.001] and correlated with LPS (Rs = 0.585; P < 0.001). Escherichia coli DNA was positive in 34% of STEMI vs. 12% of SA and 4% of controls (P < 0.001). In a subgroup of 12 STEMI, immunohistochemical analysis of coronary thrombi showed positivity for leucocyte Toll-like receptor 4 (TLR4), cathepsin G, and LPS from E. coli in 100%, 80%, and 25% of samples, respectively. E. coli-LPS injected in mice to reach LPS concentrations like those detected in coronary thrombi was associated with enhanced artery thrombosis and platelet activation, an effect blunted by TLR4 inhibitor co-administration. In vitro study demonstrated that LPS from E. coli enhanced platelet aggregation via TLR4-mediated leucocyte cathepsin G activation. CONCLUSION: ST-elevation myocardial infarction patients disclose an enhanced gut permeability that results in LPS translocation in human circulation and eventually thrombus growth at site of artery lesion via leucocyte-platelet interaction.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Carnevale R, Sciarretta S, Valenti V, et al. Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction. Eur Heart J. 2020. PMID: 31898723. doi:10.1093/eurheartj/ehz893

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。